WHO releases its first guidelines on GLP-1s
The World Health Organization (WHO) connected Monday issued its first-ever planetary guidelines connected the usage of GLP-1 medications for treating obesity arsenic a chronic illness. In a property release, the WHO said this guidance aimed to assistance trim the “skyrocketing wellness costs” associated with obesity, which are projected to person a planetary economical outgo of…





